ResearcherUniversity of Chieti-PescaraActive in the last 2 years
Alessandro Cama
Matched on ORCID iD 0000-0003-3647-1368; OpenAlex author ID A5049350757. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 1, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 2 papers · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper
Papers 13
- Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses. Co-author DOI 10.3390/cancers16101795↗
- Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. Co-author DOI 10.3390/ijms24031977↗
- High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results f… Co-author DOI 10.3390/cancers14194748↗
- Anesthetics and Long Term Cancer Outcomes: May Epigenetics Be the Key for Pancreatic Cancer? First author DOI 10.3390/medicina58081102↗
- Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Tar… Co-author DOI 10.3390/ph15080937↗
- Exosomes as Pleiotropic Players in Pancreatic Cancer. Co-author DOI 10.3390/biomedicines9030275↗
- Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. Last author DOI 10.3390/cancers13163946↗
- Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents. Last author DOI 10.1080/14756366.2020.1780228↗
- The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. Last author DOI 10.3390/cancers12071849↗
- High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12885-019-5616-2↗
- The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer. Co-author DOI 10.3390/cancers11122042↗
- Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells. Last author DOI 10.1186/s13046-018-0904-2↗
- Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines. Co-author DOI 10.1111/cbdd.13026↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rosalba Florio · 11 shared papers, 2017–2024 · strength 1.29
- Paper Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Func… DOI 10.3390/cancers16101795↗
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structu… DOI 10.3390/ph15080937↗
- Laura De Lellis · 11 shared papers, 2017–2024 · strength 1.29
- Paper Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Func… DOI 10.3390/cancers16101795↗
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structu… DOI 10.3390/ph15080937↗
- Serena Veschi · 9 shared papers, 2018–2024 · strength 1.09
- Paper Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Func… DOI 10.3390/cancers16101795↗
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946↗
- Davide Brocco · 7 shared papers, 2020–2024 · strength 0.94
- Paper Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Func… DOI 10.3390/cancers16101795↗
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946↗
- Nicola Tinari · 6 shared papers, 2018–2022 · strength 0.66
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946↗
- Paper Exosomes as Pleiotropic Players in Pancreatic Cancer. DOI 10.3390/biomedicines9030275↗
- Paper The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective. DOI 10.3390/cancers12071849↗
- Paola Lanuti · 4 shared papers, 2018–2024 · strength 0.52
- Paper Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Func… DOI 10.3390/cancers16101795↗
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Pa… DOI 10.3390/cancers14194748↗
- Rosa Amoroso · 4 shared papers, 2017–2023 · strength 0.44
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structu… DOI 10.3390/ph15080937↗
- Paper The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Panc… DOI 10.3390/cancers11122042↗
- Zhirajr Mokini · 2 shared papers, 2021–2022 · strength 0.39
- Pierluigi Di Sebastiano · 3 shared papers, 2018–2022 · strength 0.29
- Paper High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Pa… DOI 10.3390/cancers14194748↗
- Paper High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-019-5616-2↗
- Paper Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in p… DOI 10.1186/s13046-018-0904-2↗
- Patrice Forget · 1 shared paper, 2022 · strength 0.26
- Alessandra Ammazzalorso · 2 shared papers, 2017–2022 · strength 0.20
- Paper Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structu… DOI 10.3390/ph15080937↗
- Paper Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic can… DOI 10.1111/cbdd.13026↗
- Anna Piro · 1 shared paper, 2024 · strength 0.16
- Fabio F. di Mola · 1 shared paper, 2022 · strength 0.11
- Maria Cristina Curia · 1 shared paper, 2019 · strength 0.10
- Francesca Tavano · 1 shared paper, 2019 · strength 0.10
- Clara Natoli · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.